menu search

Reneo pharmaceuticals to participate in svb securities therapeutics forum

IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...

June 30, 2023, 12:25 pm

Baudax bio shares jump on acquisition of teraimmune

Shares of Baudax Bio BXRX, -1.85% jumped 25% premarket on Friday after the company announced the acquisition of TeraImmune, a privately held biotech d...

June 30, 2023, 8:18 am

Black diamond therapeutics announces pricing of public offering of common stock

CAMBRIDGE, Mass and NEW YORK, June 29, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

June 30, 2023, 12:57 am

: fda approves biomarin’s gene therapy drug for hemophilia

BioMarin Pharmaceutical Inc. BMRN received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agency said ...

June 29, 2023, 11:02 pm

Fda approves biomarin's gene therapy drug for hemophilia

BioMarin Pharmaceutical Inc. BMRN, -3.57% received Food and Drug Administration approval of its gene therapy Roctavian to treat hemophilia A, the agen...

June 29, 2023, 7:02 pm

Here's why you should retain myriad genetics (mygn) stock now

Investors are optimistic about Myriad Genetics (MYGN) due to the performance of its oncology business a...

June 28, 2023, 10:36 am

Global plant phenotyping market is expected to be worth us$ 497.4 million at cagr of 11% during forecast period 2023 to 2033 | future market insights, inc.

The increasing importance of sustainable crop production is a prime factor augmenting the growth of the global plant phenotyping market. Plant Phenoty...

June 27, 2023, 2:30 pm

Reneo pharmaceuticals added to russell 2000® and russell 3000® indices

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the ...

June 26, 2023, 12:25 pm

Opgen subsidiary ares genetics successfully maintains key patent under opposition in europe

Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants for the diagnosis of antibiotic res...

June 26, 2023, 11:30 am

Lgnd vs. ilmn: which stock is the better value option?

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already ...

June 23, 2023, 1:24 pm

Marinus: transforming the seizure market with ganaxolone (rating upgrade)

Marinus Pharmaceuticals has pivoted from postpartum depression to focus on seizure disorders, leading to FDA approval for Ztalmy (ganaxolone) for trea...

June 22, 2023, 5:55 pm

Us fda approves argenx's therapy for muscle-weakening disease

The U.S. Food and Drug Administration has approved Argenx SE's under-the-skin injection for the treatment of a muscle-weakening g...

June 20, 2023, 6:26 pm

Biomea fusion to present late breaking data from ongoing phase ii trial, covalent-111, evaluating bmf-219 in patients with type 2 diabetes at ada 2023

REDWOOD CITY, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company ...

June 20, 2023, 4:30 pm

Gsk vs. tech: which stock should value investors buy now?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider eit...

June 20, 2023, 1:16 pm

Cadeler a/s and eneti inc. sign business combination agreement to create a leading offshore wind turbine and foundation installation company

MONACO, June 16, 2023 (GLOBE NEWSWIRE) — Cadeler A/S (OSE: CADLR) (“Cadeler”) and eneti Inc. (NYS...

June 16, 2023, 5:54 am

Cibus applauds the genetic technology (precision breeding) act 2023 passed in the united kingdom

Provisions of Act aim to facilitate development and marketing of gene edited crops in the United Kingdom The Act aligns regulation of new technologies...

June 15, 2023, 12:45 pm

Neogen (neog) introduces improved genomic test for cats

Neogen's (NEOG) My CatScan 2.0 offers insightful genetic information that enables preventive cat care b...

June 15, 2023, 11:02 am

23andme: revenue growth and secular trend, but lack of profits makes it a hold

23andMe entered its IPO with two down years on revenue but has since reclaimed low double-digit growth. Throughout this time, however, the company has...

June 15, 2023, 1:44 am

5 biotech stocks to buy as industry prospects for 2h23 look good

New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Gen...

June 13, 2023, 10:32 am

Myriad genetics' (mygn) new pact to use mrd testing platform

Myriad Genetics (MYGN) announces research collaboration with MD Anderson on metastatic RCC with its hig...

June 13, 2023, 9:17 am


Search within

Pages Search Results: